CJC-1295 NO DAC 5mg
$30.00 $21.0030% OFF
CJC-1295 (No DAC) 5mg
Synthetic GHRH analogue studied for pulsatile growth hormone release, pituitary receptor signaling, and endocrine pathway research.
- 5mg lyophilized peptide
- GHRH receptor pathway research
- Pulsatile GH signaling models
- For research use only
Out of stock
CJC-1295 (No DAC) 5mg
Growth hormone–releasing hormone (GHRH) analogue studied for pulsatile GH signaling and pituitary pathway research.
Compound Overview
CJC-1295 (No DAC) is a synthetic analogue of growth hormone–releasing hormone (GHRH) designed for research applications involving pituitary signaling and growth hormone regulation pathways. Unlike DAC-modified variants, the non-DAC version maintains a shorter active duration, allowing researchers to evaluate pulsatile hormone-release models under controlled conditions.
In laboratory environments, CJC-1295 (No DAC) is studied for its interaction with GHRH receptors located in the anterior pituitary. Activation of these receptors is associated with downstream signaling cascades influencing endogenous growth hormone secretion and related endocrine feedback mechanisms.
Receptor Activity
Targets GHRH receptors to stimulate growth hormone release within experimental endocrine signaling models.
Research Focus Areas
Commonly evaluated in studies involving pulsatile GH secretion, IGF-1 pathway interactions, and pituitary-endocrine feedback systems.
Laboratory Classification
Classified as a synthetic GHRH analogue for experimental and analytical research applications.
Product Specifications
- Product Name: CJC-1295 (No DAC)
- Peptide Type: GHRH analogue
- Quantity: 5mg per vial
- Form: Lyophilized peptide powder
- Modification: Non-DAC (shorter active duration)
- Intended Use: Research use only
Be the first to review “CJC-1295 NO DAC 5mg”
Related products
Reviews
There are no reviews yet.